RIKEN to Regroup Following STAP Saga

The Japanese institution will downsize, rename, and relaunch the research center at the heart of the stimulus-triggered acquisition of pluripotency controversy.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, JULOResearchers from the RIKEN Center for Developmental Biology in Kobe, Japan, today announced they have so far been unable to reproduce the stimulus-triggered acquisition of pluripotency (STAP) method reported in two now-retracted studies led by RIKEN researcher Haruko Obokata, ScienceInsider reported. RIKEN will also downsize and rename the Center for Developmental Biology before relaunching it in November under new management.

The Nikkei Asian Review initially reported that the center’s staff of some 400 researchers could be nearly halved. However, during a press conference, RIKEN President Ryoji Noyori said the relaunched center—tentatively called the Multicellular System Formation Research Center—would employ around 250 researchers, “with the remaining staff moved to other RIKEN institutes,” ScienceInsider reported.

“This latest twist is no surprise and just adds to the continuing STAP sadness,” wrote Paul Knoepfler from the University of California, Davis, at his blog, “but hopefully is another step toward an end for the STAP disaster.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies